Abstract: Purpose of present study involves the development of floating microspheres of metronidazole as a model drug, using the modified solvent diffusion evaporation technique. Eudragit S100 and Eudragis RS100 were used in the different ratio as polymers for development of microspheres. The microspheres were characterized for surface morphology by SEM, yield, buoyancy, incorporation efficiency and micromeritic properties. The in-vitro drug release studies were performed in simulated gastric fluid at pH 1.2. Different kinetic models were also applied on drug release from selected formulations. Stability studies were additionally subjected for optimized formulations. The yield of microspheres was good. Microspheres showed satisfactory flow properties. SEM confirmed the spherical size, perforated smooth surface and a hollow cavity in them. Microspheres exhibited floating properties for more than 10 hours. Stability studies showed no significant change in residual drug content of floating Microspheres.
Introduction
The oral cavity is still the preferred site for the administration of therapeutic agents for the human body. Gastroretentive oral dosage forms designed to prolong gastric residence time and to control the drug release have gained increasing interest. By combining prolonged gastric residence time and controlled-release characteristics gastroretentive drugdelivery systems improve the bioavailability of drugs and may lead to a reduction of drug toxicity by avoiding uncontrolled plasma peak concentrations [1] .
A gastroretentive dosage form that releases the drug in a controlled manner is required to extend the absorption phase of drugs characterized by a limited and narrow absorption window at the upper part of the gastrointestinal tract or drugs intended for treatment of local ailments in the gastric region. This mode of administration may prolong the time in which the blood drug concentrations are within the "therapeutic levels" and improve therapy [2] .The prolongation of gastric residence time of the delivery system could be achieved by the mechanism of mucoadhesion, flotation, expansion, sedimentation, modified shape system, or by the simultaneous administration of pharmacological agents who delay the gastric emptying [3] .
In the present study, enhancement of gastric residence time is based on the mechanism of flotation. Floating drug-delivery systems are less dense than the gastric fluid. Most of the floating systems are dominated by single unit formulation. These single-unit dosage forms have the disadvantages of a high variability of GI transit time due to its "all or none" emptying process [4] .
However, the multiple unit particulate dosages forms pass through the GIT to avoid the vagaries to gastric emptying and thus release drug more uniformly. The uniform distribution of these multi-unit dosage forms along the GIT could result in more reproducible drug absorption and reduce the risk of local irritation than the use of single unit dosage forms [5] .
Metronidazole is a bactericidal antibiotic that belongs to the nitroimidazole group of drugs. It is actively released into the gastric juice [6] and its antimicrobial activity is only marginally affected by low pH [7] . Nitroimidazoles are given as a prodrug that needs to be activated within the target cell by one or two electron transfer processes. This reduction leads to the formation of nitro-anion radicals, and imidazole intermediates that cause lethal damage to subcellular structures, and DNA [8] .
Metronidazole is an active adjunct in treatment of H. pylori with the commonly reported side effects, including anorexia, nausea, vomiting and epigastric pain [9] .
In the present study, the multiple-unit-type oral floating hollow microspheres bearing metronidazole were developed by modified solvent evaporation technique [10] . Formulation was optimized by changing the ratio of the polymers (Eudragit S100 and Eudragit RS100) to get the spherical shape with desired features. The high surface tension of stirring phase causes the solidification and aggregation of polymer on the surface when the polymeric solution is poured from upside [12] . To minimize the contact of polymer solution with an interface, a new method of introducing the polymer solution into stirring phase [13] .
Materials and Methods

Materials
Metronidazole IP was obtained as a gift sample from Aarti Drugs Limited, Mumbai. Eudragit S100 and Eudragit RS100 were procured as a gift sample from Degussa India Pvt. Ltd. Mumbai. Polyvinyl alcohol, Molecular Wt. 14,000 was purchased from S.D. Fine Chem. Limited. All other chemicals were of analytical grade and used without further purification.
Formulation and optimization of floating microspheres
Modified procedure for the preparation of floating microspheres by solvent diffusion-evaporation method
Microspheres with an internal hollow structure were prepared by modified solvent diffusion-evaporation method. Total sixteen formulations of hollow microspheres were developed in four varied groups (A, B, C and D). Different ratios of polymers (Eudragit S-100 and Eudragit RS100) and metronidazole was mixed in a mixture of Dichloromethane (DCM) and ethanol (ETN) ( Table 1 ). The resulting solution was added slowly into stirring to 250 ml aqueous PVA at room temperature from the bottom side as shown in Fig. 1 . The stirring was continued for two hours at defined rpm by a mechanical stirrer equipped with four blade propellers. After evaporation of solvent, microspheres were collected by filtration, washed repeatedly with water. The collected microspheres were dried at 40 o C and kept in an oven (NSW-143 Narang Scientific, India) for overnight.
Process variables
Various process variables which could affect the properties of the microspheres were identified and studied. The method of preparation was accordingly optimized and validated. The following process variables were optimized: Total 16 formulations were designed based on these variables. The composition formulation code and respectable variables used in the preparation of microspheres are given in Table 1 .
The effects of the variables were observed on particle size, percent yield of microspheres, percent drug entrapment, percent buoyancy and micromeritic properties such as bulk density, tapped density and compressibility index.
The floating microspheres (group A) were prepared by the procedure given above by taking different emulsifier concentration (aqueous PVA solution 0.25% to 1% w/v) as shown in Table 1 .
After optimizing emulsifier concentration, stirring rate was optimized by preparing the microspheres (group B) at different stirring rate as 300, 400, 500 and 600 rpm and keeping other variables constant.
After optimizing emulsifier concentration and stirring rate, microspheres were optimized for the solvent ratio. In the preparation of floating microspheres (group C) two solvents, ethanol and dichloromethane were taken. The composition of solvent phase, i.e. ethanol: dichloromethane was varied.
After optimizing all other variables, floating microspheres (group D) were prepared using different polymer ratios (Eudragit S100: Eudragit RS100) to control the release rate of the drug. The data are shown in Table 1 . 
Characterization of Floating Microspheres
The surface morphology of optimized floating microspheres was visualized by Scanning Electron Microscopy (SEM). The samples for SEM were prepared by lightly sprinkling the microspheres powder on a double adhesive tape which stuck to an aluminium stub. The stubs were then coated with gold to a thickness of about 300 A using a sputter coater [11] . These samples were then randomly scanned and photomicrographs were taken, which are shown in Fig. 2-8 . The floating microspheres were examined by optical photomicroscope RXLr-3T (Radical Instruments). Dried powder of microspheres was homogenously mixed in glycerol. The prepared slide was examined, and size of the microspheres was measured. Around 250 particles from each formulation were measured, and the observed data of each formulation is presented in Table 2 -5.
Percentage Yield of Floating Microspheres
The prepared microspheres were collected and weighed. The weight of microspheres was divided by the total weight of all the non-volatile components used for the preparation of the microspheres multiplied by 100 gives the % yield of microspheres as given in following equation 11. (Table 2-5) Actual weight of the product
Total weight of the excipients and drug
Percentage Buoyancy of Floating Microspheres
Weight of floating microspheres after time t
Initial weight of Microspheres
Incorporation Efficiency
To determine the incorporation efficiency, 10 mg microspheres were taken in an iodine flask and dissolved in 10 ml of methanol. Iodine flask was kept on the rotary flask shaker (MSW-301 Mac, Delhi) for 24 hours. The solution was filtered to separate shell fragments. After sufficient dilution with methanol, the estimation of drug was carried out by using a UV double-beam spectrophotometer (Shimadzu UV-1700, Japan) at the λmax of 311 nm. The incorporation efficiency was calculated in triplicate using following equation. (Table 2 -5).
Calculated drug content Incorporation Efficiency= -------------------------------× 100
Theoretical drug content
Micromeritic Properties
The prepared microspheres were characterized for their micromeritic properties such as bulk density, tapped density, percent compressibility index or Carr's index and angle of repose. Bulk density (gm/cm 3 ) was determined by pouring three gm microspheres into a 10 ml graduated cylinder via a funnel and measuring the volume "as is." The bulk density was then obtained by dividing the weight of sample (g) by the final volume in cm 3 of the sample contained in the cylinder using following equation. (Table 2 -5)
Bulk volume of microspheres Tapped density was determined by placing a 10 ml graduated cylinder containing 3.0 gm of microspheres on to a hard surface followed by tapings until volume reached a minimum [14] . Tapped density was measured using following equation. (Table  2 -5)
Mass of Microspheres Tapped Density = --------------------------------------------------Volume of Microspheres after tapping
Carr and Neumann developed a simple test to evaluate flowability of a powder by comparing bulk density and tapped density of a powder [15] . Carr's index or compressibility index was measured using following equation. (Table 2-5) Tapped density -Bulk density
Tapped density
When only gravity acts, a static heap of powder will tend to form a conical mound, but one limitation exists as the angle to the horizontal cannot exceed a certain value known as the angle of repose (θ). 14 Flow characteristic such as the angle of repose (θ) of the microspheres, which measures the resistance to particle flow, was determined by fixed funnel method. A known weight of microspheres was allowed to flow through a funnel fixed at a constant height (h), to drop on a graph paper placed on the smooth surface of a tile. The height (h) and radius (r) of the pile of microspheres was recorded, and angle of repose calculated from the formula as follows. (Table 2 -5)
Where, h= height of pile; r = radius of the base of pile on the graph paper. 
In-vitro Drug Release
The drug release rate on all the batches of floating microspheres was determined by using USP XXIII type II i.e. paddle type dissolution apparatus [16] . A weighted amount of floating microspheres equivalent to 200 mg of metronidazole was placed in a non-reacting muslin cloth that had a smaller mesh size than the microspheres. The mesh was tied with a nylon thread to avoid the escape of any microspheres, and a magnetic bead was used in the mesh to induce the sinking of microspheres in the dissolution medium [17] . The dissolution test was performed in 900 ml simulated gastric fluid (pH 1.2) with tween 20 (0.02% w/v).
At specified time intervals, five ml aliquots were withdrawn, filtered, diluted with the same medium and assayed at 277 nm for metronidazole using a UV double-beam spectrophotometer (Shimadzu UV-1700 Japan). Samples withdrawn were replaced with equal volume of the same dissolution medium. All the experiments as specified above were conducted in triplicate. (Fig. 9-12 
Kinetics of Drug Release
The zero-order rate [18] ( Equation 1) describes systems where the drug release is independent on its concentration, and this is applicable to the dosage forms like transdermal system, coated forms, osmotic system as well as matrix tablets with low soluble drugs. Where, Q t is the amount of drug released at time t, k 0 is release rate constants for zero-order. The first-order equation [19] (Equation 2) describes systems in which the release is dependent on its concentration (generally seen for water-soluble drugs in the porous matrix).
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ln Q t = ln Q 0 -k 1 t ………………………………………… (2) Where, Qt is the amount of drug released at time t, Q 0 is the initial amount of the drug in the formulation, k 1 is release rate constants for first-order.
The Higuchi model [20] describes the release of the drug from an insoluble matrix to be linearly related to the square root of time and is based on Fickian diffusion (Equation 3).
Where, Qt is the amount of drug released at time t, k H is release rate constants for Higuchi model.
The Hixson-Crowell Cube Root Kinetics Equation (Equation 4) describes the relationship between drug release and dissolution time where it depends on the change in surface area and diameter of the particles or tablets with time and mainly applies in the case of systems that dissolute or erode over time [21] .
Where, Qt is the amount of drug released at time t, Q 0 is the initial amount of the drug in the formulation.
The Peppas-Ritger Equation was developed to describe the influence of polymeric hydration and swelling on drug release rate. The equation has been modified by Korsmeyer (Equation 5) to simplify the relationship between drug diffusion from the matrix tablet and the dissolution time [22] .
Mt / M∞ = k t n ……………………………………………… (5) Where, M t /M∞ is the fraction of drug release, k is a release rate constant, n is the diffusional release exponent indicative of the drug release mechanism, t is the dissolution time.,
Kinetic models were applied on selected formulation batches as given in Table 6 .
Stability studies
Stability may be defined as the ability of a drug to retain its properties within specified limits throughout its shelf life. The study of stability of a pharmaceutical product is essential for three main reasons, e.g. safety of the patient, legal requirements concerned with the identity, strength, purity and quality of drug and to prevent the economic repercussions of marketing of unsuitable product.
The selected formulation of floating microspheres of metronidazole was stored in amber colored glass bottle at 4 ± 1ºC, 25 ± 1ºC and 40 ± 1ºC/ for a period of 45 days and observed for any change in percentage residual drug content and surface morphology. Sample was analyzed at the time interval of 15 days and 45 days [23] . Observations are recorded in Table 7 .
Results and Discussions
Floating microspheres of Metronidazole were prepared by modified solvent diffusion-evaporation method. The formulation mechanism of acrylic polymer hollow microspheres is reported in the literature. The polymeric solution prepared in the mixture of dichloromethane, and ethanol was emulsified in aqueous solution of PVA. Thus, ethanol diffused out of the embryonic microspheres into aqueous phase. On the other hand, dichloromethane, which could not diffuse, retained in the microspheres as core material. On keeping these microspheres at 40 o C the vapors of dichloromethane were generated, which escaped them, leaving the microspheres as a hollow sphere (floating microspheres). Total 16 formulations were formulated and optimized based on emulsifier concentration, stirring rate, solvent ratio and polymer ratio.
The emulsifier concentration was varied from 0.25 to 1.0 % w/v to optimize the amount of emulsifier. It was observed that at low emulsifier concentration, a stable emulsion was not formed as most of the droplets were greater in size and consequently, the size of the prepared microspheres was larger (89.67±11.4 µm, FM-1). At 0.5 % w/v of emulsifier concentration (FM-2) highest yield (81.6±0.23%), Incorporation efficiency (73.84±7.55%) and buoyancy (76.5±0.665%) of the microspheres was obtained. When the rotational speed of the propeller increased from 300 rpm to 600 rpm, the average particle size decreased, while maintaining its morphology.
The optimum rotation speed for this experimental system was 600 rpm, as judged from the results of maximum % yield (86.2±0.404%), buoyancy (79.0±0.754%) and Incorporation efficiency (70.06±6.52%). Below 600 rpm, the shear force was not sufficient to form stable emulsion droplets; consequently, larger droplets were formed, and they were aggregated eventually.
Formation of a stable o/w emulsion at the initial stage and the precipitation of the polymer at the surface of the dispersed droplet were the key factors in preparing desirable floating microspheres. The counter diffusion of ethanol and water through the interface between the emulsion droplet and the aqueous medium reduced the solubility of the polymer at the interface with the droplet inducing precipitation of the polymer on the surface of the emulsion droplet. The dispersed droplet of the emulsion was enclosed with a film like shell of the polymer. The effect of the solvent ratio was observed on the mean particle size, % yield, buoyancy, incorporation efficiency and micromeritic properties of the microspheres.
It has been reported that when the diffusion rate of the solvent from the emulsion droplets was too slow, microspheres coalesced together. Conversely, when the diffusion rate of solvent was too fast, the solvent could diffuse into the aqueous phase before stable emulsion droplets were developed, causing the aggregation of embryonic microspheres droplets.
To find an optimum solvent composition, the effect of various solvent ratios was investigated on various parameters. These solvents were used to dissolve the acrylic polymer in o/w solvent diffusion evaporation method. Ethanol could preferentially diffuse out into the aqueous medium while dichloromethane was diffused out more slowly and evaporated after the microspheres were nearly solidified.
As ethanol preferentially diffused out of emulsion droplets, dichloromethane became a major constituent of the internal organic phase. The Eudragit S100, not being soluble in the interface between dichloromethane and water, started to solidify around dichloromethane rich emulsion droplets and the volume of dichloromethane within the droplets became a size determining factor. So, when the amount of dichloromethane was increased, the size of the microspheres was increased (81.3±11.03 µm, FM-7). The effect of the polymer ratio (Eudragit S100 and Eudragit RS100) in the organic phase on the formation of microspheres was evaluated by keeping other variables constant.
The yield of the microspheres was found to be 63.6 ± 0.916 (FM-10) to 86.2 ±0.404 % (FM-6) However, the average particle size increased 63.88 ± 18.58 µ m (FM-10) to 98.13 ± 15.93 µ m (FM-15) as shown in table 2-5.
It is reported that increase in particle size, as the amount of polymer was increased is due to diminished shearing efficiency at higher concentration of the polymer (higher viscosity).
Morphology SEM photo micrograph confirmed that prepared microspheres were spherical with smooth perforated surface. The shell of the microspheres showed some porous structure, which might have caused by the evaporation of dichloromethane entrapped within the shell of microspheres with a smooth and dense skin layer. The images also confirmed that rapid evaporation of dichloromethane causes rupturing of microspheres. The figure confirmed hollowness of microspheres. SEM photomicrograph of batch FM-16 showed the population of almost equal size of floating microspheres.
Particle size was analyzed by photomicroscope. It varied from 63.88 ± 18.58 (FM-10) to 98.13 ± 15.93 µm (FM-15). The maximum and minimum percent yield was 63.6 ± 0.916 found to be (FM-10) to 87.2 ± 0.351 % (FM-9).
All microspheres showed good floating ability (68.6 ± 3.49 (FM-3) to 86.1 ± 3.08 % (FM-12) for more than 10 hours because of their low density and owing to the internal voids being completely conserved during the test. It was observed that the floating ability increased with increasing average particle size. It was also observed that the formulation prepared with higher volume of dichloromethane than ethanol (FM-7), showed better floating ability than the batch FM-6 (equal volume of dichloromethane and ethanol) and FM-8 (lower volume of dichloromethane). The reason behind this may be larger air core formation in the batch FM-7, which made them lesser dense than that of gastric fluid. The purpose of preparing floating microspheres was to extend the gastric residence time of drug; the in vitro floating behaviour was investigated in the simulated gastric fluid containing a small amount of surfactant sween 20 (0.02% w/v) agitated with a paddle at 100 rpm. Sween 20 was used to simulate the wetting action of gastric fluid under movement.
The amount of drug entrapped in the microspheres was determined by analysing the preparation with methanol. The organic phase used in the preparation consisted of dichloromethane: ethanol. It was clear that the solubility of the drug will determine the preferential location of the drug among the solvent used. Metrondazole being slightly soluble in water has good entrapment in the microspheres. One more factor that has a high entrapment of drug was the proportion of Eudragit RS100 in the polymer phase. As the proportion of Eudragit RS100 was increased, the entrapment efficiency decreased owing to high porous nature of the polymer (60.41 ± 1.90 %, FM-12). The drug entrapment efficiency of microspheres was found to be good (58.66 ± 1.00 to 75.73 ± 2.3 %).
Bulk density of all the batches of microspheres was determined and was found to be in the range of 0.698 ± 0.032 to 0.826 ± 0.034 g/cm 3 .
The measured tapped density was in range of 0.734 ± 0.008 to 0.937 ± 0.029 g/cm 3 among all groups of microspheres studied. Carr's Index or compressibility index in all batches of microspheres ranged from 1.41 ± 1.44 to 18.14 ± 9.62, which exist in between excellent to passable type of flow. The angle of repose was found to be in the range of 27.3 ± 1.75 to 39.48 ± 1.10 o showing good to passable flow except FM-1 (44.29 ± 0.574 ο ), which showed its very poor flow.
The release of metronidazole from floating microspheres was studied in simulated gastric fluid at pH 1.2. A combination of polymers was used to design a perfect gastro retentive delivery system which could release most of the drug in upper part of gastrointestinal tract. As the amount of Eudragit RS 100 used in the preparation was increased the release of the drug was also increased (96.25 ±1.16 %, FM-12) which may be due to the porous nature of Eudragit RS 100.
Release profile of drug from the microspheres of group-A indicated slight increase in cumulative % release on increasing emulsifier concentration in FM-3 (97.67 ±1.79).
Release profile of drug from the microspheres of the group-B indicated that on increasing stirring rate, there was not any significant change in cumulative % release of metronidazole. There was no significant effect of the solvent ratio (dichloromethane: ethanol) on cumulative drug release. No significant increase in cumulative drug release was observed in the case of group D formulations on increasing the ratio of polymer Eudragit RS-100, since the total amount of polymer was same (FM-13, FM-14 and FM-1, FM-16). All release kinetic models were applied on formulation FM-6, FM-10, FM-11, FM-12, FM-13, FM-14, FM-15, FM-16 (group D). The best-fit model was found to be Hixon-Crowell (FM-6, FM-11, FM-13, FM-15), first order (FM-10), matrix (FM-12, FM-14, FM-16). All the batches of group D have the n value more than 0.5, indicating that the drug transport followed the non fickian trend.
Stability studies were performed on batch FM-15 and FM-16, because of their good floating ability and incorporation efficiency. These formulations were studied for percentage residual drug content for 45 days at the interval of 15 days. The storage temperature was 4 ± 1°C, 25 ± 1°C, and 40 ± 1°C respectively. None of the formulations showed the significant changes in percentage residual drug content during the study.
Conclusion
The objective of present study was to prepare and evaluate the floating microspheres of metronidazole as a model drug to increase its residence time in the stomach without contact with the mucosa for the better treatment of stomach and duodenal ulcers, gastritis and oesophagitis.
Metronidazole has been shown to be an effective antibacterial and antiprotozoal agent. Effect of different formulation variables, i.e. concentration of emulsifier, stirring rate, solvent ratio and polymer ratio were studied on release profile and other characteristics.
The microspheres were prepared by the emulsion solvent diffusion technique using the different ratio of acrylic polymers (Eudragit S100 and Eudragit RS100). The acrylic polymers were selected to form the microspheres floating microspheres, since they have been approved by FDA and widely used in pharmaceutical industry. The yield of microspheres was good. Microspheres showed satisfactory flow properties.
SEM confirmed their spherical size, perforated smooth surface and a hollow cavity in them. Microspheres exhibited floating properties for more than 10 hours. In-vitro drug studies were performed in 0.1N HCl. Different drug release kinetics models were applied for selected batches. Stability studies showed no significant change in residual drug content of floating Microspheres.
Hollow microspheres can greatly improve the pharmacotherapy of the stomach through local drug release, leading to high drug concentration at the gastric mucosa, thus eradicating Helicobacter pylori from the sub-mucosal tissue of the stomach and making it possible to treat stomach and duodenal ulcers, gastritis and oesophagitis.
Buoyant microspheres are considered as a beneficial strategy for the treatment of gastric and duodenal cancers. From invitro drug release studies, it is concluded that by changing the ratio of polymers metronidazole release can be controlled. Microspheres of different size, drug content, different buoyancy and different micromeritic properties could be obtained by varying the formulation variables like emulsifier concentration, stirring rate, solvent ratio and polymer ratio.
The multi-unit floating metronidazole delivery system could provide clinicians with a new choice of an economic, safe and more bio-available formulation in the management of stomach ulcers, duodenal ulcers and gastritis. These microspheres could be dispensed by filling them in the capsule shell. Therefore, it may be concluded that drug loaded floating microspheres are suitable delivery system for metronidazole.
